4003 ICE Study: A prospective, multi-centre, controlled, open-label, randomized phase III trial of ibandronate (I) with or without capecitabine (X) in elderly patients (pts) with early breast cancer (GBG 32)

✍ Scribed by T. Reimer; U. Nitz; J. Potenberg; B. Conrad; H. Graf; M. Just; H. Eidtmann; S. Loibl; V. Nekljudova; G. Von Minckwitz

• Book ID: 119600495
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 51 KB
• Volume: 7
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(09)70737-2